Loading...
Loading...
Tetraphase Pharmaceuticals
TTPH shares moved up 13.97% to $22.92. The volume of Tetraphase Pharmaceuticals shares traded was 512% higher than normal. Tetraphase Pharma priced 3.95 million shares of common stock at $19.00 per share.
Xilinx
XLNX shares rose 7.12% to $41.23. The volume of Xilinx shares traded was 425% higher than normal. Xilinx reported better-than-expected Q2 earnings. Wells Fargo upgraded Xilinx from Market Perform to Outperform..
Regeneron Pharmaceuticals
REGN shares climbed 8.78% to $370.64. The volume of Regeneron Pharmaceuticals shares traded was 379% higher than normal. Regeneron's EYLEA (aflibercept) injection received the FDA approval for macular edema following Retinal Vein Occlusion (RVO).
QLogic
QLGC surged 11.16% to $10.61. The volume of QLogic shares traded 346% higher than normal. QLogic reported upbeat Q2 results and announced a $100 million stock repurchase program. Summit research upgraded QLogic from Hold to Buy.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in